セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 食品 | 臨床検査試薬 | 化学工業薬品 | その他 |
|---|---|---|---|---|---|
| 売上高 | 2019/09 | 33.4億 -0.3% | 123億 -1.2% | 149億 -3.5% | 539百万 -4% |
| 2020/09 | 32.1億 -3.8% | 119億 -2.8% | 155億 +3.9% | 450百万 -16.5% | |
| 2021/09 | 33.2億 +3.2% | 147億 +23% | 178億 +15.3% | 417百万 -7.1% | |
| 2022/09 | 33.1億 -0.3% | 156億 +6.6% | 180億 +1.1% | 384百万 -8.1% | |
| 2023/09 | 33.5億 +1.3% | 142億 -9.2% | 172億 -4.6% | 370百万 -3.7% | |
| 科目 | 年度 | 食品 | 臨床検査試薬 | 化学工業薬品 | その他 |
| 売上総利益 | 2019/09 | 264百万 -4.9% | 11.5億 -4% | 12.6億 -4.8% | 86百万 +23.7% |
| 2020/09 | 256百万 -3.2% | 11.7億 +1.7% | 12.8億 +1.5% | 78百万 -8.3% | |
| 2021/09 | 261百万 +2.2% | 14.3億 +22.7% | 14.1億 +10.5% | 68百万 -13.4% | |
| 2022/09 | 251百万 -3.8% | 15.8億 +10% | 15.8億 +12.2% | 60百万 -11.5% | |
| 2023/09 | 261百万 +3.6% | 15.1億 -4.1% | 15.1億 -4.6% | 60百万 -0.3% | |
| 科目 | 年度 | 食品 | 臨床検査試薬 | 化学工業薬品 | その他 |
| 原価率 | 2019/09 | 92.1% +0.4% | 90.6% +0.2% | 91.5% +0.1% | 84.1% -3.6% |
| 2020/09 | 92% -0.1% | 90.2% -0.4% | 91.7% +0.2% | 82.6% -1.5% | |
| 2021/09 | 92.1% +0.1% | 90.2% ±0% | 92.1% +0.4% | 83.7% +1.1% | |
| 2022/09 | 92.4% +0.3% | 89.9% -0.3% | 91.2% -0.9% | 84.3% +0.6% | |
| 2023/09 | 92.2% -0.2% | 89.4% -0.5% | 91.2% ±0% | 83.8% -0.5% | |
| 科目 | 年度 | 食品 | 臨床検査試薬 | 化学工業薬品 | その他 |
| 従業員数 | 2019/09 | 18 | 63 | 76 | 7 |
| 2020/09 | 19 +5.6% | 64 +1.6% | 75 -1.3% | 6 -14.3% | |
| 2021/09 | 18 -5.3% | 68 +6.3% | 75 ±0% | 6 ±0% | |
| 2022/09 | 15 -16.7% | 69 +1.5% | 77 +2.7% | 6 ±0% | |
| 2023/09 | 15 ±0% | 73 +5.8% | 74 -3.9% | 6 ±0% |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| メディカル | ||||||
| 売上高 1Q | 2023/09 | 42.5億 | - | - | - | - |
| 2024/09 *ヶ月 | 36.4億 -14.5% | - | - | - | - | |
| 売上総利益 1Q | 2023/09 | 404百万 | - | - | - | - |
| 2024/09 *ヶ月 | 293百万 -27.3% | - | - | - | - | |
| 原価率 | 2023/09 | 90.5% | - | - | - | - |
| 2024/09 *ヶ月 | 91.9% +1.4% | - | - | - | - | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| インダストリー | ||||||
| 売上高 1Q | 2023/09 | 46億 | - | - | - | - |
| 2024/09 *ヶ月 | 41.8億 -9.3% | - | - | - | - | |
| 売上総利益 1Q | 2023/09 | 391百万 | - | - | - | - |
| 2024/09 *ヶ月 | 421百万 +7.5% | - | - | - | - | |
| 原価率 | 2023/09 | 91.5% | - | - | - | - |
| 2024/09 *ヶ月 | 89.9% -1.6% | - | - | - | - | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| アカデミア・ライフサイエンス | ||||||
| 売上高 1Q | 2023/09 | 552百万 | - | - | - | - |
| 2024/09 *ヶ月 | 518百万 -6.2% | - | - | - | - | |
| 売上総利益 1Q | 2023/09 | 75百万 | - | - | - | - |
| 2024/09 *ヶ月 | 46百万 -38.3% | - | - | - | - | |
| 原価率 | 2023/09 | 86.5% | - | - | - | - |
| 2024/09 *ヶ月 | 91.1% +4.6% | - | - | - | - | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 食品 | ||||||
| 売上高 1Q2Q 3Q | 2019/09 | 9.03億 +5.3% | 7.81億 -1.2% | 8.23億 +1.2% | 8.34億 -6.5% | 33.4億 -0.3% |
| 2020/09 | 8.46億 -6.3% | 7.76億 -0.6% | 7.71億 -6.3% | 8.19億 -1.8% | 32.1億 -3.8% | |
| 2021/09 | 8.66億 +2.4% | 8.25億 +6.2% | 8.33億 +8% | 7.91億 -3.3% | 33.2億 +3.2% | |
| 2022/09 | 8.23億 -5% | 8.05億 -2.4% | 8.12億 -2.6% | 8.67億 +9.6% | 33.1億 -0.3% | |
| 2023/09 | 8.66億 +5.3% | 8.06億 +0.1% | 8.28億 +2.1% | 8.48億 -2.2% | 33.5億 +1.3% | |
| 売上総利益 1Q2Q 3Q | 2019/09 | 69百万 -4.3% | 63百万 +3.7% | 66百万 -2.2% | 66百万 -14.6% | 264百万 -4.9% |
| 2020/09 | 65百万 -5.1% | 61百万 -3.8% | 63百万 -3.6% | 66百万 -0.1% | 256百万 -3.2% | |
| 2021/09 | 68百万 +4.4% | 62百万 +2.7% | 67百万 +6.2% | 63百万 -4.4% | 261百万 +2.2% | |
| 2022/09 | 65百万 -5.3% | 59百万 -5.9% | 62百万 -8.2% | 66百万 +4.6% | 251百万 -3.8% | |
| 2023/09 | 65百万 ±0% | 61百万 +3.6% | 68百万 +10.1% | 67百万 +1.2% | 261百万 +3.6% | |
| 原価率 | 2019/09 | 92.4% +0.8% | 91.9% -0.4% | 92% +0.3% | 92% +0.7% | 92.1% +0.4% |
| 2020/09 | 92.3% -0.1% | 92.2% +0.3% | 91.8% -0.2% | 91.9% -0.1% | 92% -0.1% | |
| 2021/09 | 92.1% -0.2% | 92.4% +0.2% | 91.9% +0.1% | 92% +0.1% | 92.1% +0.1% | |
| 2022/09 | 92.2% +0.1% | 92.7% +0.3% | 92.4% +0.5% | 92.3% +0.3% | 92.4% +0.3% | |
| 2023/09 | 92.5% +0.3% | 92.5% -0.2% | 91.8% -0.6% | 92.1% -0.2% | 92.2% -0.2% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 臨床検査試薬 | ||||||
| 売上高 1Q2Q 3Q | 2019/09 | 29.8億 -6.7% | 28億 -20.9% | 27.8億 +1.8% | 37.1億 +25.6% | 123億 -1.2% |
| 2020/09 | 29億 -2.8% | 29.2億 +4.4% | 27.7億 -0.6% | 33.4億 -9.9% | 119億 -2.8% | |
| 2021/09 | 35億 +20.7% | 38.3億 +30.9% | 35.8億 +29.5% | 37.6億 +12.7% | 147億 +23% | |
| 2022/09 | 37.6億 +7.6% | 40.2億 +4.9% | 36.1億 +0.7% | 42.5億 +13% | 156億 +6.6% | |
| 2023/09 | 39.6億 +5.2% | 35億 -12.8% | 31.5億 -12.8% | 36億 -15.4% | 142億 -9.2% | |
| 売上総利益 1Q2Q 3Q | 2019/09 | 2.78億 -1.1% | 2.77億 -20.2% | 2.6億 -0.1% | 3.35億 +8.3% | 11.5億 -4% |
| 2020/09 | 2.61億 -6.1% | 3.01億 +8.8% | 2.73億 +5.2% | 3.33億 -0.5% | 11.7億 +1.7% | |
| 2021/09 | 3.16億 +20.9% | 3.87億 +28.5% | 3.26億 +19.3% | 4.05億 +21.7% | 14.3億 +22.7% | |
| 2022/09 | 3.55億 +12.5% | 4.26億 +10.1% | 3.69億 +13.3% | 4.27億 +5.3% | 15.8億 +10% | |
| 2023/09 | 4.02億 +13% | 3.86億 -9.5% | 3.48億 -5.8% | 3.77億 -11.6% | 15.1億 -4.1% | |
| 原価率 | 2019/09 | 90.7% -0.5% | 90.1% -0.1% | 90.7% +0.2% | 91% +1.5% | 90.6% +0.2% |
| 2020/09 | 91% +0.3% | 89.7% -0.4% | 90.1% -0.6% | 90% -1% | 90.2% -0.4% | |
| 2021/09 | 91% ±0% | 89.9% +0.2% | 90.9% +0.8% | 89.2% -0.8% | 90.2% ±0% | |
| 2022/09 | 90.5% -0.5% | 89.4% -0.5% | 89.8% -1.1% | 90% +0.8% | 89.9% -0.3% | |
| 2023/09 | 89.8% -0.7% | 89% -0.4% | 89% -0.8% | 89.5% -0.5% | 89.4% -0.5% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 化学工業薬品 | ||||||
| 売上高 1Q2Q 3Q | 2019/09 | 39.1億 +2.4% | 39.2億 -12.1% | 33.1億 -4.8% | 37.2億 +2.3% | 149億 -3.5% |
| 2020/09 | 36.5億 -6.6% | 40.8億 +4% | 36.7億 +10.8% | 40.5億 +8.9% | 155億 +3.9% | |
| 2021/09 | 42億 +14.8% | 49.5億 +21.2% | 43億 +17.3% | 43.8億 +8% | 178億 +15.3% | |
| 2022/09 | 44.4億 +5.8% | 52.3億 +5.7% | 40.9億 -4.8% | 42.5億 -2.9% | 180億 +1.1% | |
| 2023/09 | 45.7億 +3% | 46.4億 -11.2% | 43億 +5% | 36.6億 -13.9% | 172億 -4.6% | |
| 売上総利益 1Q2Q 3Q | 2019/09 | 3.25億 -2% | 3.21億 -21% | 2.9億 +1.6% | 3.22億 +8.2% | 12.6億 -4.8% |
| 2020/09 | 3.07億 -5.7% | 3.34億 +4.2% | 3.05億 +5.4% | 3.31億 +2.7% | 12.8億 +1.5% | |
| 2021/09 | 3.35億 +9.1% | 4.08億 +22.1% | 3.23億 +5.9% | 3.45億 +4.3% | 14.1億 +10.5% | |
| 2022/09 | 4.08億 +22% | 4.38億 +7.3% | 3.63億 +12.3% | 3.75億 +8.5% | 15.8億 +12.2% | |
| 2023/09 | 3.95億 -3.4% | 4.15億 -5.3% | 3.56億 -1.9% | 3.46億 -7.6% | 15.1億 -4.6% | |
| 原価率 | 2019/09 | 91.7% +0.4% | 91.8% +0.9% | 91.2% -0.6% | 91.3% -0.5% | 91.5% +0.1% |
| 2020/09 | 91.6% -0.1% | 91.8% ±0% | 91.7% +0.5% | 91.8% +0.5% | 91.7% +0.2% | |
| 2021/09 | 92% +0.4% | 91.7% -0.1% | 92.5% +0.8% | 92.1% +0.3% | 92.1% +0.4% | |
| 2022/09 | 90.8% -1.2% | 91.6% -0.1% | 91.1% -1.4% | 91.2% -0.9% | 91.2% -0.9% | |
| 2023/09 | 91.4% +0.6% | 91.1% -0.5% | 91.7% +0.6% | 90.5% -0.7% | 91.2% ±0% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| その他 | ||||||
| 売上高 1Q2Q 3Q | 2019/09 | 47百万 +8% | 116百万 -0.1% | 261百万 -12.8% | 115百万 +12.4% | 539百万 -4% |
| 2020/09 | 29百万 -38.5% | 115百万 -0.7% | 215百万 -17.7% | 91百万 -20.9% | 450百万 -16.5% | |
| 2021/09 | 17百万 -39.6% | 117百万 +1.4% | 197百万 -8.2% | 86百万 -5.2% | 417百万 -7.1% | |
| 2022/09 | 20百万 +17% | 105百万 -10.3% | 193百万 -1.9% | 65百万 -24.3% | 384百万 -8.1% | |
| 2023/09 | 17百万 -18.5% | 85百万 -18.9% | 212百万 +9.4% | 57百万 -13.3% | 370百万 -3.7% | |
| 売上総利益 1Q2Q 3Q | 2019/09 | 32百万 +85.7% | 29百万 +0.1% | -12百万 赤字 | 36百万 +21.1% | 86百万 +23.7% |
| 2020/09 | 20百万 -35.1% | 24百万 -18.9% | 2.4百万 | 32百万 -12.8% | 78百万 -8.3% | |
| 2021/09 | 5.3百万 -74.2% | 37百万 +56.9% | -1.2百万 赤字 | 26百万 -16.5% | 68百万 -13.4% | |
| 2022/09 | 11百万 +117.4% | 21百万 -44.3% | 4.9百万 | 23百万 -13.4% | 60百万 -11.5% | |
| 2023/09 | 8.7百万 -24.5% | 25百万 +21.3% | 5百万 +1.2% | 21百万 -8.2% | 60百万 -0.3% | |
| 原価率 | 2019/09 | 32.8% -28.1% | 74.6% ±0% | 104.5% +2.1% | 68.4% -2.3% | 84.1% -3.6% |
| 2020/09 | 29.1% -3.7% | 79.3% +4.7% | 98.9% -5.6% | 65.2% -3.2% | 82.6% -1.5% | |
| 2021/09 | 69.7% +40.6% | 67.9% -11.4% | 100.6% +1.7% | 69.3% +4.1% | 83.7% +1.1% | |
| 2022/09 | 43.6% -26.1% | 80.1% +12.2% | 97.5% -3.1% | 64.9% -4.4% | 84.3% +0.6% | |
| 2023/09 | 47.8% +4.2% | 70.2% -9.9% | 97.7% +0.2% | 62.8% -2.1% | 83.8% -0.5% | |